Opus Point Partners Management as of March 31, 2019
Portfolio Holdings for Opus Point Partners Management
Opus Point Partners Management holds 74 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
iShares NASDAQ Biotechnology Index (IBB) | 31.8 | $24M | 210k | 111.80 | |
Direxion Shs Etf Tr sp biotch bl | 8.0 | $5.9M | 98k | 59.88 | |
Mettler-Toledo International (MTD) | 3.2 | $2.3M | 3.2k | 723.03 | |
Proqr Thrapeutics N V shs euro (PRQR) | 2.6 | $1.9M | 139k | 13.87 | |
Ionis Pharmaceuticals (IONS) | 2.2 | $1.6M | 20k | 81.15 | |
Bristol Myers Squibb (BMY) | 2.1 | $1.6M | 33k | 47.70 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $1.5M | 8.1k | 183.92 | |
Illumina (ILMN) | 2.0 | $1.5M | 4.7k | 310.59 | |
Alexion Pharmaceuticals | 1.8 | $1.3M | 9.9k | 135.19 | |
Seattle Genetics | 1.8 | $1.3M | 18k | 73.24 | |
Alnylam Pharmaceuticals (ALNY) | 1.7 | $1.2M | 13k | 93.48 | |
Immunomedics | 1.6 | $1.2M | 63k | 19.21 | |
Qiagen Nv | 1.6 | $1.2M | 29k | 40.68 | |
Spark Therapeutics | 1.5 | $1.1M | 9.7k | 113.93 | |
Bluebird Bio (BLUE) | 1.2 | $919k | 5.8k | 157.36 | |
Incyte Corporation (INCY) | 1.2 | $913k | 11k | 86.03 | |
Regeneron Pharmaceuticals (REGN) | 1.2 | $904k | 2.2k | 410.72 | |
Uniqure Nv (QURE) | 1.1 | $848k | 14k | 59.66 | |
BioMarin Pharmaceutical (BMRN) | 1.1 | $808k | 9.1k | 88.80 | |
Celgene Corporation | 1.1 | $803k | 8.5k | 94.36 | |
Insmed (INSM) | 1.1 | $783k | 27k | 29.07 | |
Ascendis Pharma A S (ASND) | 1.0 | $729k | 6.2k | 117.77 | |
Audentes Therapeutics | 0.9 | $677k | 17k | 39.04 | |
Intercept Pharmaceuticals In | 0.9 | $644k | 5.8k | 111.88 | |
Epizyme | 0.8 | $624k | 50k | 12.39 | |
Gw Pharmaceuticals Plc ads | 0.8 | $619k | 3.7k | 168.48 | |
Biohaven Pharmaceutical Holding | 0.8 | $559k | 11k | 51.51 | |
Blueprint Medicines (BPMC) | 0.7 | $543k | 6.8k | 80.09 | |
Macrogenics (MGNX) | 0.7 | $541k | 30k | 17.99 | |
EXACT Sciences Corporation (EXAS) | 0.7 | $528k | 6.1k | 86.66 | |
Zogenix | 0.7 | $535k | 9.7k | 55.01 | |
Regenxbio Inc equity us cm (RGNX) | 0.7 | $506k | 8.8k | 57.29 | |
Amicus Therapeutics (FOLD) | 0.7 | $500k | 37k | 13.61 | |
Global Blood Therapeutics In | 0.7 | $502k | 9.5k | 52.96 | |
Intellia Therapeutics (NTLA) | 0.7 | $487k | 29k | 17.09 | |
Viking Therapeutics (VKTX) | 0.7 | $482k | 49k | 9.94 | |
Crispr Therapeutics (CRSP) | 0.6 | $472k | 13k | 35.72 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $447k | 3.6k | 125.21 | |
Anaptysbio Inc Common (ANAB) | 0.6 | $447k | 6.1k | 73.09 | |
Arena Pharmaceuticals | 0.6 | $438k | 9.8k | 44.83 | |
Deciphera Pharmaceuticals | 0.6 | $432k | 19k | 23.19 | |
Pacira Pharmaceuticals (PCRX) | 0.6 | $428k | 11k | 38.04 | |
Fortress Biotech | 0.6 | $417k | 234k | 1.78 | |
Supernus Pharmaceuticals (SUPN) | 0.6 | $408k | 12k | 35.03 | |
Cellectis S A (CLLS) | 0.6 | $409k | 22k | 18.33 | |
Sarepta Therapeutics (SRPT) | 0.5 | $388k | 3.3k | 119.31 | |
Rubius Therapeutics | 0.5 | $391k | 22k | 18.09 | |
Wave Life Sciences (WVE) | 0.5 | $377k | 9.7k | 38.80 | |
Ultragenyx Pharmaceutical (RARE) | 0.5 | $351k | 5.1k | 69.31 | |
Nektar Therapeutics (NKTR) | 0.5 | $346k | 10k | 33.58 | |
Amarin Corporation (AMRN) | 0.5 | $345k | 17k | 20.73 | |
G1 Therapeutics | 0.5 | $346k | 21k | 16.60 | |
Xencor (XNCR) | 0.5 | $340k | 11k | 31.09 | |
ACADIA Pharmaceuticals (ACAD) | 0.4 | $322k | 12k | 26.88 | |
Agios Pharmaceuticals (AGIO) | 0.4 | $324k | 4.8k | 67.42 | |
Checkpoint Therapeutics | 0.4 | $323k | 113k | 2.86 | |
Sangamo Biosciences (SGMO) | 0.4 | $320k | 34k | 9.54 | |
Charles River Laboratories (CRL) | 0.4 | $307k | 2.1k | 145.36 | |
Bio-techne Corporation (TECH) | 0.4 | $308k | 1.6k | 198.58 | |
Iqvia Holdings (IQV) | 0.4 | $286k | 2.0k | 144.08 | |
Alkermes (ALKS) | 0.4 | $282k | 7.7k | 36.52 | |
Exelixis (EXEL) | 0.4 | $272k | 11k | 23.78 | |
Cytomx Therapeutics (CTMX) | 0.4 | $272k | 25k | 10.76 | |
Grifols S A Sponsored Adr R (GRFS) | 0.4 | $263k | 13k | 20.10 | |
Fibrogen (FGEN) | 0.4 | $262k | 4.8k | 54.28 | |
United Therapeutics Corporation (UTHR) | 0.3 | $258k | 2.2k | 117.33 | |
Surface Oncology | 0.3 | $253k | 53k | 4.77 | |
Neurocrine Biosciences (NBIX) | 0.3 | $247k | 2.8k | 87.99 | |
Amgen (AMGN) | 0.3 | $236k | 1.2k | 190.02 | |
Gilead Sciences (GILD) | 0.3 | $238k | 3.7k | 64.90 | |
Ligand Pharmaceuticals In (LGND) | 0.3 | $219k | 1.7k | 125.50 | |
Ac Immune Sa (ACIU) | 0.3 | $201k | 40k | 5.05 | |
Intrexon | 0.2 | $170k | 32k | 5.27 | |
Recro Pharma | 0.1 | $67k | 11k | 5.90 |